Rheumato
MDPI AG · Switzerland
Aims & Scope✦ Inferred from recent articles
Rheumato focuses on the study and treatment of rheumatic and inflammatory diseases. The journal covers topics such as the pathogenesis of conditions like Behcet disease, juvenile idiopathic arthritis, and rheumatoid arthritis, including the role of immune cells and genetic factors. It also addresses therapeutic strategies, including biologic disease-modifying antirheumatic drugs, Janus kinase inhibitors, and treat-to-target approaches, as well as the management of associated complications like cardiovascular and renal issues. The scope extends to autoinflammatory bone disorders, fibromyalgia, and the impact of psychological factors and lifestyle on rheumatic conditions.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about Rheumato
Is Rheumato a predatory journal?
PubScope has no integrity flags on record for Rheumato: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 52/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Rheumato?
Rheumato is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.
Is Rheumato indexed in Scopus and Web of Science?
Rheumato is indexed in DOAJ.
How much does it cost to publish in Rheumato?
Rheumato charges an article processing charge (APC) of about CHF 1,000 for open-access publication.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref